A SCOTTISH medical diagnostics business has secured £1.5 million of new investment following the completion of a second fundraising round.
Led by the investment syndicate Kelvin Capital, and with Scottish Investment Bank participation, the oversubscribed funding round will support the continued commercial development of Biotangents’ diagnostic platform technology which is used to quickly detect infectious diseases of livestock.
The funding will be used to launch their initial products, developed in-house, into the market.
The technology provides vets with the ability to diagnose potentially fatal diseases in cattle – on-site and within the same day – allowing farmers to isolate an infected animal quickly and limit spread within the herd. Traditional processes involve off-site lab testing which can take up to seven days for results to come in, significantly increasing the risk of other animals becoming infected.
The Kelvin Capital syndicate, is led by directors John McNicol and Angus Hay, and represents private investors in the UK, Europe and the US.
Alan Hale, chief executive at Biotangents, said: “The global medical diagnostics market is vast and presents a range of opportunities for us to become a global leader in the engineering of biology to produce fast, sensitive, reliable and easy-to-use diagnostic products.
“We already know that our diagnostic platform technology can have a real impact on identifying infectious diseases, quickly, in animals and that our patent-pending design can be adapted for use in many other products and applications.
He continued: “Our focus right now is on addressing the diagnostics of Bovine viral diarrhoea – a highly contagious viral disease of cattle. The financial costs alone of failing to diagnose that disease early can cost farmers up to £470 per animal, and it is responsible for £61 million of losses each year in the UK alone. If we can successfully roll out our test internationally then we can realise an enormous market opportunity.”
Biotangents is based at the Pentlands Science Park just outside Edinburgh. The firm was founded in 2015 to apply the expertise they had developed in gene technologies to improving the sustainability of traditional industries.
This led them to invent (patent pending) Moduleic Sensing™, a versatile diagnostic technology that has the potential to be used across multiple sectors including human healthcare and environmental monitoring.
They began working with Kelvin Capital in 2017 and raised over £1m of seed funding made up by investment and grants.
John McNicol, director of Kelvin Capital said: “The diagnostics market for livestock infectious diseases is growing due to increasing awareness of the impact that disease outbreaks can have on food security and public health.
“We need only look back to the £8 billion cost of the 2001 foot and mouth disease outbreak to highlight the enormous cost that infectious diseases can have.
“We invested in Biotangents in its first round of funding in 2017 and we are delighted to continue to back the business with a further syndicate investment.
He added: “It is a business that is not only bringing rapid improvements to livestock care leading to public health improvements but it is also disrupting a traditional industry with its advanced technology which is very exciting.”
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here